Sciegen Pharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SCIEGEN PHARMS INC, and what generic and branded alternatives to SCIEGEN PHARMS INC drugs are available?
SCIEGEN PHARMS INC has sixty-three approved drugs.
Drugs and US Patents for Sciegen Pharms Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sciegen Pharms Inc | VALSARTAN | valsartan | TABLET;ORAL | 204038-002 | Oct 27, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Sciegen Pharms Inc | DROXIDOPA | droxidopa | CAPSULE;ORAL | 214017-001 | Feb 18, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Sciegen Pharms Inc | PREGABALIN | pregabalin | CAPSULE;ORAL | 208677-007 | Jul 19, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Sciegen Pharms Inc | AMLODIPINE AND OLMESARTAN MEDOXOMIL | amlodipine besylate; olmesartan medoxomil | TABLET;ORAL | 209010-001 | Dec 3, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Sciegen Pharms Inc | SOLIFENACIN SUCCINATE | solifenacin succinate | TABLET;ORAL | 211657-001 | May 20, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.